Cargando…

Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report

Neurofibromatosis type 1 (NF1) is an autosomal dominant inherited disease that is characterized by the presence of multiple neurofibromas, café-au-lait spots and iris hamartomas. It is well established that the incidence of tumors in patients with NF1 is high compared with the normal population and...

Descripción completa

Detalles Bibliográficos
Autores principales: ISHIDA, MITSUAKI, OKABE, HIDETOSHI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796415/
https://www.ncbi.nlm.nih.gov/pubmed/24137429
http://dx.doi.org/10.3892/ol.2013.1490
_version_ 1782287472995074048
author ISHIDA, MITSUAKI
OKABE, HIDETOSHI
author_facet ISHIDA, MITSUAKI
OKABE, HIDETOSHI
author_sort ISHIDA, MITSUAKI
collection PubMed
description Neurofibromatosis type 1 (NF1) is an autosomal dominant inherited disease that is characterized by the presence of multiple neurofibromas, café-au-lait spots and iris hamartomas. It is well established that the incidence of tumors in patients with NF1 is high compared with the normal population and that the majority of the tumors are non-epithelial neoplasms, including neurofibromas, malignant peripheral nerve sheath tumors, gliomas and leukemia. Studies have suggested that patients with NF1 also have a significantly higher risk of certain types of carcinomas. However, the occurrence of cutaneous squamous cell carcinoma (SCC) in a patient with NF1 is extremely rare. The present study describes the second documented case of a cutaneous SCC adjacent to a neurofibroma of the forehead with histopathological analyses in a patient with NF1. An 80-year-old female with NF1 presented with a rapidly growing skin tumor of the forehead. Histopathological study of the resected forehead tumor demonstrated that there were two tumorous lesions. One was an invasive SCC and the other was a neurofibroma. The lesions were adjacent, but no continuity was present. NF1 is caused by inactivating mutations in the NF1 gene and loss of heterozygosity of this gene has been reported in neurofibromas, malignant peripheral nerve sheath tumors, gliomas and pheochromocytomas in patients with NF1. However, the genetic mechanism of carcinoma development in patients with NF1 is not well understood. Studies have suggested the role of the NF1 and/or the BRCA gene in the occurrence of breast cancer. Additional studies are required to elucidate these mechanisms.
format Online
Article
Text
id pubmed-3796415
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-37964152013-10-17 Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report ISHIDA, MITSUAKI OKABE, HIDETOSHI Oncol Lett Articles Neurofibromatosis type 1 (NF1) is an autosomal dominant inherited disease that is characterized by the presence of multiple neurofibromas, café-au-lait spots and iris hamartomas. It is well established that the incidence of tumors in patients with NF1 is high compared with the normal population and that the majority of the tumors are non-epithelial neoplasms, including neurofibromas, malignant peripheral nerve sheath tumors, gliomas and leukemia. Studies have suggested that patients with NF1 also have a significantly higher risk of certain types of carcinomas. However, the occurrence of cutaneous squamous cell carcinoma (SCC) in a patient with NF1 is extremely rare. The present study describes the second documented case of a cutaneous SCC adjacent to a neurofibroma of the forehead with histopathological analyses in a patient with NF1. An 80-year-old female with NF1 presented with a rapidly growing skin tumor of the forehead. Histopathological study of the resected forehead tumor demonstrated that there were two tumorous lesions. One was an invasive SCC and the other was a neurofibroma. The lesions were adjacent, but no continuity was present. NF1 is caused by inactivating mutations in the NF1 gene and loss of heterozygosity of this gene has been reported in neurofibromas, malignant peripheral nerve sheath tumors, gliomas and pheochromocytomas in patients with NF1. However, the genetic mechanism of carcinoma development in patients with NF1 is not well understood. Studies have suggested the role of the NF1 and/or the BRCA gene in the occurrence of breast cancer. Additional studies are required to elucidate these mechanisms. D.A. Spandidos 2013-10 2013-07-25 /pmc/articles/PMC3796415/ /pubmed/24137429 http://dx.doi.org/10.3892/ol.2013.1490 Text en Copyright © 2013, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
ISHIDA, MITSUAKI
OKABE, HIDETOSHI
Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report
title Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report
title_full Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report
title_fullStr Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report
title_full_unstemmed Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report
title_short Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report
title_sort cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: a case report
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796415/
https://www.ncbi.nlm.nih.gov/pubmed/24137429
http://dx.doi.org/10.3892/ol.2013.1490
work_keys_str_mv AT ishidamitsuaki cutaneoussquamouscellcarcinomainapatientwithneurofibromatosistype1acasereport
AT okabehidetoshi cutaneoussquamouscellcarcinomainapatientwithneurofibromatosistype1acasereport